Windlas Biotech And Mateon Therapeutics Launch First-Ever drug-Device Lung Therapy Combined AI 360 Platform For Respiratory Wellness
Windlas Biotech Pvt. Ltd. (Windlas), a leading Indian pharmaceutical contract drug development and manufacturing organization, in partnership with Mateon Therapeutics, Inc. (Mateon), a US-based oncology company focusing on TGF-β inhibitors…
Share